During 2011-2015, U.S. Cardiovascular Surgery Devices Market Grows at a CAGR of 7%

Published Date : Nov 01, 2013

The U.S. market for cardiovascular surgery devices is mainly dominated by the heart valves which are followed by perfusion systems and cardiac assist devices. RNCOS a leading syndicate market research and consultancy firm reports that, U.S. market for cardiovascular surgery devices comprising of cardiac assist devices, heart valves, and perfusion systems is expected to reach a benchmark of U.S. $1.8 billion market by the end of 2015. 


The research report also reveals that although the segment of cardiovascular surgery devices is a positive generator for the cardiac device market in U.S., however, it is still facing difficulty and stiff resistance in its growth because of the increased competition from other less invasive natured alternatives such as endovascular and transcatheter. 


The report thoroughly covers all the major key aspects regarding the U.S. cardiac medical device market and its effective analysis of the current as well as the expected position of the market in the future. 


Furthermore, the RNCOS also investigates the role of the major authorities associated with the cardiac devices as well as covers every detail of the regulatory framework regarding the same. It also analyzes the present performance of different industry segments like interventional cardiology, cardiac rhythm management, and cardiovascular surgery, and the majority share of other sub-segments. 


The RNCOS report is an elaborate research and in-depth analysis of the overall condition of U.S. cardiac medical devices market and its future status and size during 2012-2015. This report is a good way to provide apt analysis of competitors dealing with cardiac medical devices, and also analyze the opportunity assessment for various companies covering topics like financial overview, business description, key developments, and strengths and weaknesses in the U.S. cardiac medical devices market. 


In brief, the report is meant to cater the clients with in-depth knowledge and statistics in the U.S. cardiac medical devices domain.